Ferronova: Funding, Investors & Team (Sep 2026)
A patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology from Victoria University of Wellington have been combined by Ferronova, an innovative medical device company, to create an advanced diagnostic system to enhance the detection of cancer metastases. Ferronova collaborates on research with the Universities of Sydney, New South Wales, and UniSA Future Industries Institute. Ferronova was founded in 2016 and is supported by Uniseed, Artesian Ventures, Powerhouse Ventures, an ASX-listed investment firm, PAN Ventures, UniSA Ventures, and Wellington UniVentures. The governments of South Australia and Australia have contributed grants to help develop the technology.
Ferronova has raised $11.6M across 2 funding rounds on record, the most recent a Series A of $6.0M announced in Dec 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ferronova Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Ferronova Funding Rounds
Ferronova raised $5.6M in a Series B announced in Jan 2023.
2.9 years later, a Series A of $6.0M was announced in Dec 2025.
Ferronova Founders and Leadership Team
No contact details are on record for this team yet.
Ferronova Funding Compared to Other Biotechnology Startups
Ferronova's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ferronova in Biotechnology and Adelaide
Companies Similar to Ferronova
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Ferronova Funding FAQs
What does Ferronova do?
A patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology from Victoria University of Wellington have been combined by Ferronova, an innovative medical device company, to create an advanced diagnostic system to enhance the detection of cancer metastases. Ferronova collaborates on research with the Universities of Sydney, New South Wales, and UniSA Future Industries Institute. Ferronova was founded in 2016 and is supported by Uniseed, Artesian Ventures, Powerhouse Ventures, an ASX-listed investment firm, PAN Ventures, UniSA Ventures, and Wellington UniVentures. The governments of South Australia and Australia have contributed grants to help develop the technology.
How much funding has Ferronova raised?
Ferronova has raised $11.6M across 2 rounds on record. The most recent is a Series A of $6.0M announced in Dec 2025.
When did Ferronova last raise funding?
Ferronova's most recent funding round on record is a Series A of $6.0M, announced in Dec 2025.
Who founded Ferronova?
FundedIQ lists Benjamin Thierry (Founder) at Ferronova.
Where is Ferronova headquartered?
Ferronova is based in Adelaide, South Australia, Australia.
How many employees does Ferronova have?
Ferronova is in the 11-50 employee band.
How does Ferronova's funding compare to other Biotechnology startups?
Ferronova's latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Ferronova Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ferronova is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.